Leverkus et al., 2005 - Google Patents
Follicular cutaneous T‐cell lymphoma: beneficial effect of isotretinoin for persisting cysts and comedonesLeverkus et al., 2005
- Document ID
- 11987765717709401906
- Author
- Leverkus M
- Rose C
- Bröcker E
- Goebeler M
- Publication year
- Publication venue
- British Journal of Dermatology
External Links
Snippet
SIR, Follicular (pilotropic) mycosis fungoides (MF) is a rare variant of cutaneous T-cell lymphoma (CTCL) that manifests with neoplastic lymphocytes mainly in the epithelium of hair follicles. 1–3 Clinical features of follicular MF include prominent lesional or perilesional …
- 201000005962 mycosis fungoide 0 title abstract 12
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dummer et al. | Randomized phase III trial evaluating spartalizumab plus dabrafenib and trametinib for BRAF V600–mutant unresectable or metastatic melanoma | |
| Robert et al. | Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study | |
| Strazzula et al. | Intralesional sodium thiosulfate for the treatment of calciphylaxis | |
| Zaragoza et al. | High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma | |
| Sánchez‐Regaña et al. | Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy) | |
| Chai et al. | Management of stage I squamous cell carcinoma of the anal canal | |
| Ye et al. | Pyoderma gangrenosum: a review of clinical features and outcomes of 23 cases requiring inpatient management | |
| Harting et al. | Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma | |
| Leverkus et al. | Follicular cutaneous T‐cell lymphoma: beneficial effect of isotretinoin for persisting cysts and comedones | |
| Philipp et al. | Combination of adalimumab with traditional systemic antipsoriatic drugs–a report of 39 cases | |
| Daniels et al. | Analgesic efficacy and safety of a novel injectable formulation of diclofenac compared with intravenous ketorolac and placebo after orthopedic surgery: a multicenter, randomized, double-blinded, multiple-dose trial | |
| Nikolaou et al. | Monotherapy and combination therapy with acitretin for mycosis fungoides: results of a retrospective, multicentre study | |
| Duvic et al. | Results from a phase I/II open-label, dose-finding study of pralatrexate and oral bexarotene in patients with relapsed/refractory cutaneous T-cell lymphoma | |
| Gisondi et al. | Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome | |
| Foss et al. | Clinical efficacy of romidepsin in tumor stage and folliculotropic mycosis fungoides | |
| Gordon et al. | Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod | |
| Chan et al. | Outcomes based on albumin‐bilirubin (ALBI) grade in the phase III CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC) | |
| Bögemann et al. | Using data from a sickness fund claims database to assess the treatment patterns and healthcare resource utilization among patients with metastatic renal cell carcinoma in Germany | |
| Hurd et al. | Limb salvage does not predict functional limb outcome after revascularization for traumatic acute limb ischemia | |
| Rahman et al. | Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry | |
| Weber et al. | Outcomes with postrecurrence systemic therapy following adjuvant checkpoint inhibitor treatment for resected melanoma in checkmate 238 | |
| Ceccarelli et al. | Sneddon-wilkinson disease and monoclonal gammopathy of undetermined significance in the elderly: case report | |
| Vaidyanathan et al. | Chronic prostatitis: Current concepts | |
| Sohal et al. | Do patients with pancreatic body or tail cancer benefit from adjuvant therapy? A cohort study | |
| Kiracofe et al. | Incidence of oxandrolone induced hepatic transaminitis in patients with burn injury |